Updates

RWS - Reports best ever year

November 2017

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

It looks like Andrew Brode, chairman and founder of the UK-based language service provider (LSP) RWS has had a rush of blood to the head. During the month, it announced the bolt on acquisition of Article One Partners (an online crowdsourcing platform linking clients to researchers) for US$8m. This was followed with the huge acquisition of Czech-based Moravia for US$320m from its private equity owners Clarion Capital, part funded by a placing of shares to raise £185m at 425p, a 21% discount on the previous day.According to RWS, Moravia’s revenues grew from US$100.3m in 2014 to US$159.2m in 2016 and it has grown ebitda by 53% from US$11.6m to US$27.1m in this time - so RWS is paying 11.8x trailing ebitda.Separately, ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Medica

Benchmark

RWS (November 2016)

RWS (January 2016)

RWS (January 2014)

RWS - Unblemished 10 year record of growth (October 2013)

RWS - Unblemished 10 year record of growth (July 2013)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X